Global Solid Dosage Form Drug Market Growth (Status and Outlook) 2023-2029

Global Solid Dosage Form Drug Market Growth (Status and Outlook) 2023-2029

The global Solid Dosage Form Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Solid Dosage Form Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Solid Dosage Form Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Solid Dosage Form Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Solid Dosage Form Drug players cover Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.

LPI (LP Information)' newest research report, the “Solid Dosage Form Drug Industry Forecast” looks at past sales and reviews total world Solid Dosage Form Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Solid Dosage Form Drug sales for 2023 through 2029. With Solid Dosage Form Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Dosage Form Drug industry.

This Insight Report provides a comprehensive analysis of the global Solid Dosage Form Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Dosage Form Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Solid Dosage Form Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Dosage Form Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Dosage Form Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Solid Dosage Form Drug market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Tablet
Capsules
Other

Segmentation by application
Hospital
Retail Pharmacy
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Teva
Boehringer Ingelheim
Biogen
Astellas

Please note: The report will take approximately 2 business days to prepare and deliver.